Team
Carl Athayde
Carl is Founder and CEO of CAadvisory Pte Ltd, a Singapore-based boutique firm established in 2010, where he assists venture and private equity stage companies source growth capital (equity, debt or hybrid) throughout Asia Pacific. He focuses on Tech, Healthcare and Consumer sectors, and occasionally consults with Family Offices on the buy side. He also co-founded Circle Labs, a San Francisco-based wellness company. He has worked with Boards and is currently on the Asia Board of Wishbone Medical, Inc.
Prior to CAadvisory, Carl worked in leading global banks on both the Institutional as well as the Private Client desks, most recently as a Senior Client Partner at ANZ Private Bank Asia where he collaborated with their debt capital markets, loan syndications and M&A functions. Previously, he was a Senior Banker at Clariden Leu, the pure play private banking boutique of the Credit Suisse Group, and the Market Head/ EVP for Thailand/ Indo-China desk at Coutts Private Bank, all in Singapore. Carl started his banking career in 1991 at Standard Chartered in HK and Singapore, mostly in the corporate bank, before moving to ABN AMRO, latterly as the FI Sales Head, APAC.
Carl was a post-graduate Rotary Foundation scholar at the University of Illinois, U.S.A (A.M.), prior to which he earned a master’s degree at the Tata Institute of Social Sciences, India and a bachelor’s degree at St. Xavier’s College, India. He also completed the Wharton SMU general management program in Singapore.
Carl previously served on the board of Dana-Asia, an organization focused on charitable giving. He has also presented to diverse forums such as INSEAD and the University of Michigan Executive Development Program. He was appointed Co- Chairperson – US Department of Commerce Trade Mission, 2019 and 2020.
Carl is currently a Mentor at 500 Startups, a Consulting Partner at R3i-sponsored HODT and HOMT (House of DeepTech/ MedTech), and an Entrepreneur-in-Residence at INSEAD.
The firm collaborates with a range of advisors and institutions, as appropriate, to help secure our historically-high success rates.